UTime to acquire Bowen Therapeutics to enhance monkeypox vaccine development
UTime Limited (NASDAQ: WTO), a prominent player in the healthcare sector, has officially signed a non-disclosure agreement (NDA) to acquire Bowen Therapeutics Inc, including its ... Read More
Dynavax begins clinical trial for new shingles vaccine candidate, Z-1018
Dynavax Technologies Corporation, a renowned player in the biopharmaceutical sector, has made headlines with the initiation of a Phase 1/2 clinical trial for its innovative ... Read More
Sun Pharma collaborates with ICGEB to develop affordable dengue vaccine
Sun Pharma, an Indian multinational pharmaceutical company, has announced a collaboration with the International Centre for Genetic Engineering and Biotechnology (ICGEB) to develop a new ... Read More